25gr. Glucomedics vs 25gr. Zusto

Bart Keymeulen

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Dietary Supplement: Zusto; Dietary Supplement: Glucomedics®

Study type: Interventional

Funder types: Other

Identifiers

NCT02607345

2015/030

Details and patient eligibility

About

Objective: to compare blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr Zusto® and 100ml water sweetened with 25gr Glucomedics® (standard drink)

Full description

This is an experimental study enrolling 10 healthy female subjects. The study compares the blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr Zusto® and 100ml water sweetened with 25gr Glucomedics® (standard drink). Subjects need to be fasted for at least 8 hours before all visits. At visit 1, five women will consume the solution with 25gr Zusto®, the other five will have the solution with 25gr Glucomedics®. On visit 2, groups will be switched. Visit 1 and 2 will be performed within approximately one week interval.

Both drinks will be identical in amount of water and only be different by the use of 25gr Glucomedics® and 25gr Zusto®.

Before intake of the drink, vital signs, weight and bedside blood glucose and baseline blood samples - 15' and 0' for glucose, insulin and C-peptide will be taken at visit 1 and 2. Both drinks will be consumed within 5 minutes and time of start and end of intake of Zusto® / Glucomedics® will be documented.

Blood samples for glucose, insulin and C-peptide will be taken at 15', 30', 60', 90', 120' and 180' after start of intake 25gr Zusto® and 25gr Glucomedics®.

Enrollment: 10 patients

Sex: Female

Ages: 30 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Female subjects
• Age between 30 and 50 years
• BMI between 20 and 30 kg/m²

Exclusion criteria

• No first degree relatives with mellitus type 1 or type 2
• No intake of medication with influence blood glucose levels
• Pregnant, breast feeding or planning to become pregnant during the study
• Employer of the investigator or study center with direct involvement in the proposed study or other studies under the direction of the investigator or study center

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

10 participants in 2 patient groups

Glucomedics®

Active Comparator group

Description:

25gr Glucomedics®

Treatment:

Dietary Supplement: Glucomedics®

Zusto®

Experimental group

Description:

25gr Zusto®

Treatment:

Dietary Supplement: Zusto